Chandra Bhagat Pharma Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Chandra Bhagat Pharma Ltd with 125 companies shown from the same industry classification, including Gujarat Terce Laboratories Ltd, Bacil Pharma Ltd, Murae Organisor Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Chandra Bhagat Pharma Ltd | 28.8 Cr. | 38.2 | 53.0/29.7 | 9.45 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 27.6 Cr. | 35.4 | 59.8/29.0 | 12.4 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Bacil Pharma Ltd | 33.0 Cr. | 23.0 | 61.8/10.6 | 52.4 | 17.6 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.44/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Colinz Laboratories Ltd | 18.5 Cr. | 73.5 | 87.9/36.1 | 37.0 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Checkpoint Trends Ltd | 17.3 Cr. | 31.6 | 144/28.4 | 14.1 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 41.3 Cr. | 9.56 | 22.6/7.11 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 13.6 Cr. | 91.0 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Beryl Drugs Ltd | 12.7 Cr. | 25.0 | 27.6/15.9 | 20.5 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| ANG Lifesciences India Ltd | 45.0 Cr. | 34.4 | 49.7/17.6 | 47.6 | 0.00 % | 1.14 % | 7.38 % | 10.0 | |
| Dipna Pharmachem Ltd | 10.2 Cr. | 3.89 | 25.0/3.89 | 3.89 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Adline Chem Lab Ltd | 9.24 Cr. | 15.8 | 16.2/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 48.6 Cr. | 30.2 | 46.8/25.6 | 101 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| Brawn Biotech Ltd | 7.62 Cr. | 25.4 | 25.7/17.7 | 8.96 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Mangalam Drugs and Organics Ltd | 51.8 Cr. | 32.4 | 73.0/22.7 | 65.3 | 0.00 % | 13.8 % | 34.8 % | 10.0 | |
| Decipher Labs Ltd | 5.75 Cr. | 5.69 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.49 Cr. | 0.83 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| Evoq Remedies Ltd | 4.08 Cr. | 1.64 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| Vivimed Labs Ltd | 57.6 Cr. | 6.84 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| Cian Healthcare Ltd | 63.6 Cr. | 25.4 | 25.4/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| Fervent Synergies Ltd | 74.4 Cr. | 14.9 | 26.0/13.0 | 20.4 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Denis Chem Lab Ltd | 90.7 Cr. | 65.4 | 94.6/56.1 | 11.4 | 66.0 | 3.83 % | 14.0 % | 9.52 % | 10.0 |
| Concord Drugs Ltd | 93.5 Cr. | 71.0 | 92.5/61.0 | 45.8 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Vaishali Pharma Ltd | 103 Cr. | 7.91 | 11.2/4.75 | 24.3 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Pharmaids Pharmaceuticals Ltd | 106 Cr. | 30.1 | 53.9/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Alpa Laboratories Ltd | 122 Cr. | 58.3 | 99.8/46.0 | 28.0 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Achyut Healthcare Ltd | 126 Cr. | 5.21 | 10.0/4.70 | 393 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Krebs Biochemicals & Industries Ltd | 132 Cr. | 60.4 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Lactose (India) Ltd | 135 Cr. | 107 | 136/76.0 | 19.4 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Auro Laboratories Ltd | 138 Cr. | 222 | 317/159 | 28.9 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 139 Cr. | 9.49 | 14.3/1.96 | 46.3 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Par Drugs & Chemicals Ltd | 141 Cr. | 114 | 180/78.0 | 9.71 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Godavari Drugs Ltd | 141 Cr. | 129 | 135/69.7 | 36.2 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Bal Pharma Ltd | 157 Cr. | 98.5 | 125/59.7 | 21.9 | 51.6 | 1.22 % | 9.75 % | 7.79 % | 10.0 |
| Coral Laboratories Ltd | 193 Cr. | 540 | 679/360 | 10.2 | 585 | 0.37 % | 11.0 % | 7.79 % | 10.0 |
| Nectar Lifescience Ltd | 197 Cr. | 10.2 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Brooks Laboratories Ltd | 203 Cr. | 69.0 | 131/36.3 | 15.4 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Gennex Laboratories Ltd | 237 Cr. | 9.77 | 17.2/7.05 | 12.6 | 9.16 | 0.00 % | 11.8 % | 10.5 % | 1.00 |
| Everest Organics Ltd | 241 Cr. | 242 | 536/197 | 45.9 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| BDH Industries Ltd | 264 Cr. | 458 | 610/340 | 22.5 | 134 | 1.09 % | 20.5 % | 14.8 % | 10.0 |
| Lyka Labs Ltd | 287 Cr. | 79.6 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| Aarey Drugs & Pharmaceuticals Ltd | 338 Cr. | 106 | 110/50.3 | 81.2 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Albert David Ltd | 462 Cr. | 804 | 932/580 | 20.5 | 686 | 0.62 % | 0.82 % | 0.44 % | 10.0 |
| Wanbury Ltd | 668 Cr. | 191 | 360/162 | 15.5 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Kilitch Drugs (India) Ltd | 800 Cr. | 230 | 268/117 | 26.6 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Anuh Pharma Ltd | 866 Cr. | 87.2 | 99.5/66.7 | 19.6 | 35.1 | 1.72 % | 14.9 % | 10.7 % | 5.00 |
| Themis Medicare Ltd | 997 Cr. | 108 | 141/65.0 | 43.3 | 0.46 % | 2.74 % | 0.41 % | 1.00 | |
| Bafna Pharmaceuticals Ltd | 1,049 Cr. | 451 | 451/94.8 | 135 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Lincoln Pharmaceuticals Ltd | 1,084 Cr. | 543 | 770/440 | 11.2 | 378 | 0.33 % | 16.0 % | 12.0 % | 10.0 |
| Kopran Ltd | 1,374 Cr. | 284 | 296/107 | 55.0 | 110 | 1.06 % | 6.65 % | 4.91 % | 10.0 |
| TTK Healthcare Ltd | 1,448 Cr. | 1,016 | 1,250/735 | 18.9 | 789 | 0.98 % | 8.04 % | 6.30 % | 10.0 |
| Amrutanjan Health Care Ltd | 1,456 Cr. | 503 | 760/476 | 23.4 | 128 | 0.97 % | 24.8 % | 18.4 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,475 Cr. | 224 | 265/155 | 31.4 | 41.2 | 1.79 % | 22.7 % | 17.3 % | 2.00 |
| Fermenta Biotech Ltd | 1,587 Cr. | 540 | 583/249 | 29.0 | 138 | 0.69 % | 20.6 % | 16.4 % | 5.00 |
| Hester Biosciences Ltd | 1,849 Cr. | 2,165 | 2,684/1,239 | 34.8 | 423 | 0.51 % | 15.2 % | 15.9 % | 10.0 |
| Beta Drugs Ltd | 1,884 Cr. | 1,700 | 2,808/990 | 41.3 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Venus Remedies Ltd | 2,107 Cr. | 1,574 | 2,044/432 | 18.1 | 497 | 0.64 % | 20.7 % | 15.6 % | 10.0 |
| Syncom Formulations (India) Ltd | 2,108 Cr. | 22.4 | 27.5/10.2 | 24.8 | 4.39 | 0.45 % | 24.8 % | 17.6 % | 1.00 |
| Indoco Remedies Ltd | 2,149 Cr. | 233 | 302/162 | 102 | 0.09 % | 0.96 % | 9.36 % | 2.00 | |
| Panacea Biotec Ltd | 2,211 Cr. | 360 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Dishman Carbogen Amcis Ltd | 2,393 Cr. | 153 | 306/128 | 132 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| Fredun Pharmaceuticals Ltd | 2,529 Cr. | 1,532 | 1,666/454 | 56.9 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Hikal Ltd | 2,698 Cr. | 219 | 261/146 | 63.6 | 97.2 | 0.27 % | 3.50 % | 2.21 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,016 Cr. | 269 | 420/252 | 19.1 | 146 | 1.98 % | 14.0 % | 10.2 % | 2.00 |
| Solara Active Pharma Sciences Ltd | 3,109 Cr. | 641 | 774/422 | 728 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Ind-Swift Laboratories Ltd | 3,208 Cr. | 370 | 425/87.0 | 49.3 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Kwality Pharmaceuticals Ltd | 3,525 Cr. | 3,394 | 3,949/829 | 43.2 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Unichem Laboratories Ltd | 3,665 Cr. | 520 | 687/278 | 30.0 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Aarti Drugs Limited | 3,675 Cr. | 403 | 534/319 | 21.2 | 154 | 0.50 % | 11.7 % | 12.7 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,973 Cr. | 424 | 494/270 | 43.9 | 85.9 | 0.09 % | 12.9 % | 11.9 % | 1.00 |
| Gufic BioSciences Ltd | 4,160 Cr. | 417 | 468/268 | 56.6 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| RPG Life Sciences Ltd | 4,656 Cr. | 2,818 | 3,130/1,731 | 39.9 | 366 | 0.85 % | 25.7 % | 19.3 % | 8.00 |
| Gujarat Themis Biosyn Ltd | 4,812 Cr. | 370 | 479/225 | 98.9 | 26.4 | 0.18 % | 18.1 % | 17.4 % | 1.00 |
| Zota Health Care Ltd | 4,918 Cr. | 1,420 | 1,740/1,022 | 200 | 0.07 % | 8.47 % | 15.0 % | 10.0 | |
| Orchid Pharma Ltd | 5,661 Cr. | 945 | 1,144/471 | 313 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| FDC Ltd | 5,681 Cr. | 348 | 474/313 | 18.4 | 153 | 1.43 % | 15.4 % | 11.2 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 5,973 Cr. | 204 | 224/67.1 | 33.8 | 61.3 | 0.49 % | 11.3 % | 8.42 % | 2.00 |
| Sanofi India Ltd | 6,858 Cr. | 2,983 | 4,898/2,907 | 20.0 | 359 | 2.51 % | 57.5 % | 43.0 % | 10.0 |
| Bliss GVS Pharma Ltd | 7,019 Cr. | 660 | 745/118 | 51.0 | 113 | 0.23 % | 16.9 % | 11.8 % | 1.00 |
| Morepen Laboratories Ltd | 7,056 Cr. | 128 | 151/33.0 | 60.1 | 22.8 | 0.16 % | 8.05 % | 5.33 % | 2.00 |
| Entero Healthcare Solutions Ltd | 7,349 Cr. | 1,689 | 1,920/944 | 57.0 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,869 Cr. | 868 | 1,002/584 | 36.6 | 234 | 0.40 % | 10.7 % | 8.59 % | 5.00 |
| Suven Life Sciences Ltd | 8,061 Cr. | 285 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Procter & Gamble Health Ltd | 8,723 Cr. | 5,232 | 6,975/4,700 | 26.2 | 316 | 2.96 % | 83.9 % | 61.9 % | 10.0 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Blue Jet Healthcare Ltd | 9,824 Cr. | 519 | 693/325 | 41.8 | 78.4 | 0.23 % | 26.1 % | 19.4 % | 2.00 |
| Concord Biotech Ltd | 13,948 Cr. | 1,331 | 1,627/987 | 49.0 | 193 | 0.57 % | 17.4 % | 12.6 % | 1.00 |
| Marksans Pharma Ltd | 14,245 Cr. | 314 | 351/155 | 27.6 | 66.7 | 0.29 % | 18.8 % | 15.2 % | 1.00 |
| Astrazeneca Pharma India Ltd | 14,863 Cr. | 5,955 | 9,850/5,640 | 85.7 | 349 | 0.60 % | 29.3 % | 23.3 % | 2.00 |
| Jubilant Pharmova Ltd | 14,950 Cr. | 939 | 1,185/784 | 38.5 | 445 | 0.53 % | 8.99 % | 6.53 % | 1.00 |
| Natco Pharma Ltd | 15,344 Cr. | 783 | 1,217/781 | 13.4 | 470 | 0.64 % | 17.4 % | 17.1 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 15,588 Cr. | 792 | 998/635 | 20.9 | 289 | 1.51 % | 12.6 % | 13.4 % | 2.00 |
| ERIS Lifesciences Ltd | 16,035 Cr. | 1,156 | 1,740/1,138 | 24.5 | 282 | 0.63 % | 14.1 % | 18.7 % | 1.00 |
| Cohance Lifesciences Ltd | 17,054 Cr. | 446 | 918/267 | 158 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| Caplin Point Laboratories Ltd | 17,721 Cr. | 2,330 | 2,991/1,500 | 26.6 | 443 | 0.34 % | 24.2 % | 20.9 % | 2.00 |
| Pfizer Ltd | 17,946 Cr. | 3,925 | 5,448/3,731 | 23.3 | 919 | 1.91 % | 24.1 % | 18.0 % | 10.0 |
| Shilpa Medicare Ltd | 18,817 Cr. | 962 | 1,096/260 | 66.2 | 132 | 0.06 % | 10.9 % | 8.99 % | 1.00 |
| Granules India Ltd | 22,036 Cr. | 806 | 924/520 | 33.9 | 205 | 0.22 % | 15.5 % | 13.8 % | 1.00 |
| Acutaas Chemicals Ltd | 25,816 Cr. | 3,160 | 3,740/1,476 | 66.8 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Neuland Laboratories Ltd | 25,927 Cr. | 20,200 | 24,235/11,500 | 52.1 | 1,461 | 0.17 % | 26.5 % | 21.2 % | 10.0 |
| Wockhardt Ltd | 32,314 Cr. | 1,986 | 2,422/1,087 | 81.0 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,642 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Ajanta Pharma Ltd | 41,609 Cr. | 3,343 | 3,797/2,382 | 36.7 | 362 | 0.96 % | 34.5 % | 27.1 % | 2.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 43,084 Cr. | 2,541 | 3,121/2,088 | 40.9 | 134 | 2.25 % | 61.4 % | 45.6 % | 10.0 |
| Ipca Laboratories Ltd | 48,468 Cr. | 1,912 | 2,039/1,252 | 35.3 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Gland Pharma Ltd | 50,260 Cr. | 3,043 | 3,171/1,574 | 35.6 | 656 | 0.66 % | 17.4 % | 12.8 % | 1.00 |
| Abbott India Ltd | 55,889 Cr. | 26,295 | 30,655/25,135 | 34.6 | 2,247 | 2.00 % | 44.8 % | 34.4 % | 10.0 |
| Biocon Ltd | 57,235 Cr. | 351 | 447/338 | 78.7 | 210 | 0.14 % | 3.61 % | 1.40 % | 5.00 |
| Glenmark Life Sciences Ltd | 62,243 Cr. | 2,210 | 2,538/1,793 | 20.0 | 372 | 0.23 % | 39.8 % | 23.6 % | 1.00 |
| Alkem Laboratories Ltd | 62,514 Cr. | 5,214 | 5,934/5,051 | 27.5 | 1,156 | 1.02 % | 21.2 % | 18.9 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 63,298 Cr. | 2,244 | 2,538/1,793 | 20.3 | 372 | 0.22 % | 39.8 % | 23.6 % | 1.00 |
| Lupin Ltd | 89,026 Cr. | 1,953 | 2,530/1,900 | 15.0 | 491 | 0.92 % | 29.9 % | 28.7 % | 2.00 |
| Aurobindo Pharma Ltd | 95,771 Cr. | 1,663 | 1,740/1,080 | 25.3 | 652 | 0.24 % | 12.9 % | 10.1 % | 1.00 |
| Mankind Pharma Ltd | 96,568 Cr. | 2,335 | 2,642/1,910 | 42.7 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,01,367 Cr. | 1,214 | 1,415/1,080 | 31.5 | 454 | 0.66 % | 13.0 % | 11.2 % | 1.00 |
| Cipla Ltd | 1,06,029 Cr. | 1,313 | 1,673/1,166 | 29.6 | 426 | 0.99 % | 15.5 % | 11.6 % | 2.00 |
| Laurus Labs Ltd | 1,10,502 Cr. | 2,037 | 2,071/870 | 127 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,74,505 Cr. | 4,580 | 5,250/3,483 | 78.2 | 248 | 0.83 % | 15.2 % | 27.4 % | 5.00 |
| Industry Average | 17,076.32 Cr | 1,211.61 | 52.97 | 211.25 | 0.40% | 26.15% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Chandra Bhagat Pharma Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Chandra Bhagat Pharma Ltd analysis · Explore all Pharmaceuticals stocks